ClinicalTrials.gg
RecruitingNCT05927519Updated Oct 28, 2024

Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study

An interventional study of airtraq video laryngoscope in Obesity, Morbid, Intubation; Difficult or Failed and Video Laryngoscope, sponsored by Kocaeli University. Recruiting at 2 sites in Turkey. Open to male participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-10-28.

Sponsored by Kocaeli University · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 70 studies in Obesity, Morbid with a site in Turkey — 8 open to participants now, 8 under way, 1 of them phase 3. Obesity, Morbid · Turkey.

Planned enrollment
13th of 38
80 · median 66
Started
2024
with 3 others
No phase
33 of 70
2 open now
Registered
46th of 70
by date

Among the 70 studies in Obesity, Morbid with a site in Turkey, this one is the 13th largest by planned enrollment of the 38 interventional ones that give a count, is one of 4 that started in 2024, is one of 33 with no phase, and was the 46th registered.

Obesity, Morbid

941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.

Browse Obesity, Morbid studies →

Open to participants now

8 of the 70 studies in Obesity, Morbid with a site in Turkey are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 80 Years · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Obesity, Morbid with a site in Turkey, or all of them as a file.
02

Study summary

Morbid obesity is a growing disease. Intubations of these patients mostly difficult. Video laryngoscopes have to be used during the intubation of these patients. The intubation of men is more complicated and difficult than obese women. There were no trials compared to the new video laryngoscopes in morbidly obese men. Patients will be divided into two groups; non-obese and klas 2-3 obese. Airtraq will be used for their intubation. The time for intubation will be the primary aim of this prospective randomized study. The insertion time, perioperative hemodynamic variables, and postoperative complications will also be recorded.

Read the detailed description

Morbid obesity is a growing disease. Intubations of these patients mostly difficult. Video laryngoscopes have to be used during the intubation of these patients. The intubation of men is more complicated and difficult than obese women. There were no trials compared to the new video laryngoscopes in morbidly obese men. Patients will be divided into two groups; non-obese and klas 2-3 obese. Airtraq will be used for their intubation. The time for intubation will be the primary aim of this prospective randomized study. The insertion time, need of optimization menuvers, perioperative hemodynamic variables, and postoperative complications will also be recorded.

03

Conditions studied

  • Obesity, Morbid
  • Intubation; Difficult or Failed
  • Video Laryngoscope
  • Men

Browse trials for

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:> 18 age men gender elective operation requring intuabtion -

Exclusion Criteria:\<18 age women emergency operation

-

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    morbidly obese

    Class 2 (bmı \>35) weight kg/height m2 and class 3 (bmı\>40) obese men

    Device: airtraq video laryngoscope

  • Placebo comparator
    nonobese

    bmı\<30 weight kg/ height m2 men

    Device: airtraq video laryngoscope

Interventions

  • Deviceairtraq video laryngoscope

    airtraq video laryngoscope will be used for intubations

06

What researchers measure

Primary outcomes

  1. intubation time

    the intubation time will be recorded beginning the insertion of the Airtraq through the mouth still the endotracheal tube seen passing through the vocal cords

    Time frame: 50 seconds

Secondary outcomes

  1. insertion time

    inserting the Airtraq through the mouth till the optimal glottic vizualization occurred

    Time frame: 20 seconds

  2. peroperative hemodynamic variable

    heart rate

    Time frame: 4 hours

07

Study locations

1 of 2 sites recruiting
  • Kocaeli University Medical Faculty Hospital
    Iamit, 41100, Turkey
    Recruiting
  • Kocaeli UniversityMedical Faculty
    Kocaeli, 41100, Turkey
    Active, not recruiting

    Not enrolling at this site.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Oct 2027, 35 months after the start.

Of 273 non-industry interventional studies with no phase under Obesity, Morbid, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 48. This study's planned 35 months is above that.

Counting every sponsor, half of 285 studies reached it within 25 months; a quarter within 11 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 19, 2023
First posted
Jul 3, 2023
StartActual
Oct 25, 2024
Primary completionEst.
Oct 5, 2027
CompletionEst.
Oct 5, 2027
Last update
Oct 28, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05927519
Lead sponsor
Kocaeli University
Responsible party
Zehra Ipek ARSLAN (Professor, Kocaeli University) — Principal investigator
First posted
Jul 3, 2023
Start date
Oct 25, 2024
Primary completion
Oct 5, 2027 (estimated)
Completion
Oct 5, 2027 (estimated)
Last update
Oct 28, 2024

Study contacts

Zehra Arslan, professor
Contact
zehraipek48@gmail.com
00902623038168

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion